ASAlexander A. Stewart

Alexander A. Stewart

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Alexander A. Stewart has a total of 21 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    The first complete assembly for a lungless urodelan with a “miniaturized” genome, the Northern Dusky Salamander (Plethodontidae: Desmognathus fuscus)

    by Edward A Myers, Alexander A Stewart, Aidan E O’bRien, Jeramiah J Smith, R Alexander Pyron

    Salamanders have some of the largest genomes among animals, driven primarily by expansion of repeat elements and slow rates of DNA loss. However, species in the lungless genus Desmognathus (Plethodontidae) have some of the smallest genomes at ∼13 to 15 GB, though previous sequencing attempts with short-read assemblies were still fragmentary. Here, we assemble an annotated draft genome of Desmognathus fuscus using PacBio HiFi reads and transcriptomic data from 2 specimens from the same population. The combined dataset resulted in a 16.1 GB assembly in 19,632 contigs and an L/N50 of 2,459/1.74 MB, with the longest contig at 27.9 MB. This may still be slightly larger than the true size due to incomplete resolution of repeat regions. The assembly is highly complete with 93% of the 5,310 Tetrapoda BUSCO orthologs. Only 25% of the genome is single copy with 75% corresponding to transposable elements, mostly LTRs (36% of the genome) and LINEs (15%). We estimate an early expansion and slow contraction of LINEs followed by a quick recent expansion of both LTRs and DNA transposons. We identified 12,408 protein-coding genes with a common name in 1 or more reference databases. Finally, we used mother-offspring RNAseq data from an unrelated D. fuscus clutch to create a high-density linkage map, yielding 14 primary linkage groups and 2 smaller scaffolds covering 7.5 Gb and incorporating 46.5% of the genome and 60% of the mRNAs. This chromosome-scale assembly represents a new benchmark for plethodontid salamander genomics.


  • Lost and found: Rediscovery and genomic characterization of sowthistle yellow vein virus after a 30+ year hiatus

    by Drake C. Stenger, Lindsey P. Burbank, Renyuan Wang, Alexander A. Stewart, Caleb Mathias, Michael M. Goodin


  • Umbilical Cord Transforming Growth Factor-β3: Isolation, Comparison with Recombinant TGF-β3 and Cellular Localization

    by Alexander A. Stewart, John D. Haley, Guo-Y. Qu, Kees Stam, David Fenyö, Brian T. Chait, Daniel R. Marshak, A. Yuk-Kiu Ng, Garry Marley, Kenneth K. Iwata

    The transforming growth factor beta (TGF-β) family of growth modulators play critical roles in tissue development and maintenance. Recent data suggest that individual TGF-β isoforms (TGF-β1, -β2 and -β3) have overlapping yet distinct biological actions and target cell specificities, both in developing and adult tissues. The TGF-β3 isoform was purified to homogeneity from both natural and recombinant sources and characterized by laser desorption mass spectrometry, by protein sequencing, by amino acid analysis and by biological activity. TGF-β3 was the major TGF-β isoform in umbilical cord (230 ng/g), and was physically and biologically indistinguishable from recombinant TGF-β3 and from the tumor growth inhibitory (TGI) protein found in umbilical cord. Immunohistochemistry using antipeptide TGF-β3 specific antibody showed TGF-β3 localization in perivascular smooth muscle.


  • Open Access

    Physical and biological characterization of a growth-inhibitory activity purified from the neuroepithelioma cell line A673

    by K Stam, A A Stewart, G Y Qu, K K Iwata, D Fenyö, B T Chait, D R Marshak, J D Haley

    Epithelial- and haematopoietic-cell growth-inhibitory activities have been identified in the conditioned medium of the human peripheral neuroepithelioma cell line A673. An A673-cell-derived growth-inhibitory activity was previously fractionated into two distinct components which inhibited the proliferation of human carcinoma and leukaemia cells in culture. One inhibitory activity was shown to comprise interleukin-1 alpha (IL-1 alpha). Here, we have purified to homogeneity a distinct activity which inhibited the growth of the epithelial cells in vitro. Using a combination of protein-sequence analysis and mass spectrometry, we demonstrated that biological activity can be assigned to a dimeric protein with a molecular mass of 25,576 (+/- 4) Da and an N-terminal sequence identical with that of transforming growth factor-beta 1 (TGF-beta 1). Further characterization of the growth inhibitor with TGF-beta-isoform-specific antibodies showed that > 90% of the bioactivity consists of TGF-beta 1 and not TGF-beta 2 or TGF-beta 3. Although A673 cells were growth-inhibited by exogenous TGF-beta 1, we showed that TGF-beta 1 in A673-cell-conditioned media was present in the latent, biologically inactive, form which did not act as an autocrine growth modulator of A673 cells in vitro.